EU Takes Focused Approach In Bid To Deliver Decentralized Clinical Trials Guide By Year End
EU regulators are eager to roll out harmonized requirements for decentralized clinical trials by the end of 2022 and so have decided to tackle some of the notably trickier issues in greater detail later on.
You may also be interested in...
EU Aims To Drive Uptake In Decentralized Clinical Trials With Harmonized Guide
The highly anticipated pan-EU recommendation paper on decentralized clinical trials explains the factors that sponsors should consider when designing and implementing such trials.
Decentralized Trial Approaches: How Do They Match Up To Conventional Studies?
Mira Zuidgeest is the principal investigator of a key EU study that proposes to compare fully remote, hybrid and conventional clinical trial approaches. She talks to the Pink Sheet about how the study might help understand “where we're heading with decentralized clinical trials.”
EU Guidance To Tackle Sponsor/Investigator Overlap In Decentralized Trials
With sponsors of decentralized clinical trials increasingly getting involved in contracting third-party vendors to deliver services that are traditionally overseen by investigators, a much-awaited EU recommendation paper will explain how both parties can maintain control over their distinctive roles.